http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101720060-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-14 |
| filingDate | 2015-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101720060-B1 |
| titleOfInvention | Composition for preventing or treating neuromyelitis optica, comprising tryptophan derivatives or pharmaceutical acceptable salts thereof |
| abstract | The present invention relates to a vinylsulfone derivative compound which acts to prevent the binding of NMO-IgG and aquaporin 4 protein, a pharmaceutically acceptable salt thereof, and a pharmaceutical composition for preventing or treating optic nerve spondylitis containing the same as an active ingredient. |
| priorityDate | 2015-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.